References |
1 |
Ibuprofen was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
|
2 |
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48(11):689-723.
|
3 |
Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos. 2004 Nov;32(11):1201-8.
|
4 |
Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
|
5 |
Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos. 2003 Sep;31(9):1125-33.
|
6 |
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects. Br J Clin Pharmacol. 2012 May;73(5):786-94.
|
7 |
Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos. 1997 Jan;25(1):1-4.
|
8 |
Pharmacogenetics of analgesic drugs
|
9 |
Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity
|
10 |
Pharmacokinetics and metabolism of codeine in humans
|
11 |
DrugBank(Pharmacology-Metabolism):Codeine
|
12 |
Diclofenac does not interact with codeine metabolism in vivo: a study in healthy volunteers
|